• Lysoptosis: Serpins Moderate a Conserved Lysosome-Driven Cel

  2026-06-03

  The referenced study uncovers lysoptosis as a distinct, evolutionarily conserved lysosome-dependent cell death pathway regulated by intracellular serpins. This work clarifies the mechanistic separation of lysoptosis from other regulated cell death programs and has implications for manipulating cell death in disease models.

• Antimony Promotes Bladder Cancer Metastasis via SUMOylation

  2026-06-03

  This study elucidates how environmental antimony exposure accelerates bladder cancer metastasis through SUMOylation-dependent activation of the TGF-β/Smad2/3 axis. The findings highlight a molecular mechanism linking heavy metal pollution to cancer progression and suggest new therapeutic targets for intervention.

• p-Cresyl Sulfate Drives Aortic Valve Calcification via Kloth

  2026-06-02

  The referenced study uncovers how p-cresyl sulfate (p-tolyl hydrogen sulfate), a protein-bound uremic toxin, directly accelerates calcification in aortic valvular interstitial cells by suppressing klotho and SIRT1 pathways. These insights clarify the molecular links between chronic kidney disease, uremic toxins, and calcific aortic valve disease, highlighting potential targets for therapeutic intervention.

• Optimizing EAE Models: Best Practices with MOG (35-55) Pepti

  2026-06-02

  This article provides scenario-driven guidance for biomedical researchers and lab technicians deploying MOG (35-55) Peptide (SKU A8306) in autoimmune encephalomyelitis research. Evidence-based answers address experimental design, protocol optimization, data interpretation, and reliable product selection, highlighting the scientific and workflow advantages of APExBIO's MOG (35-55) Peptide.

• Nanobody Targeting PstS-1: A New Tool for Tuberculosis Imagi

  2026-06-01

  This study reports the isolation and characterization of a camelid nanobody specific to the PstS-1 protein of Mycobacterium tuberculosis. The work demonstrates the nanobody's high affinity and immunoreactivity, supporting its potential for non-invasive molecular imaging of TB granulomas.

• Early Life Adversity Disrupts Innate Defense via Oxytocin Pa

  2026-06-01

  This study demonstrates that early life adversity (ELA), modeled as postnatal social deprivation, impairs visually evoked innate defensive behaviors in mice through disruption of oxytocin signaling in the superior colliculus. These findings clarify the neural mechanisms linking early environmental stress to long-term alterations in threat processing, informing future research on neurobiological interventions.

• Reliable Cell Proliferation: EdU Imaging Kits (Cy5) in Actio

  2026-05-31

  This article explores real-world laboratory challenges in cell proliferation and genotoxicity assays, demonstrating how EdU Imaging Kits (Cy5) (SKU K1076) from APExBIO provide reproducible, sensitive solutions. Using scenario-driven Q&A, we address protocol optimization, data interpretation, and product selection with evidence-based guidance for researchers.

• Gastrin I (Human): Advancing Gastric Acid Research in Organo

  2026-05-30

  This thought-leadership article explores the integration of human Gastrin I peptide as a precision tool in next-generation gastrointestinal models—especially hiPSC-derived intestinal organoids. By weaving mechanistic insight, experimental benchmarks, and strategic guidance, it charts a path for translational researchers aiming to model, dissect, and therapeutically target gastric acid secretion pathways. The piece draws on recent literature, notably Saito et al. (2025), and situates APExBIO’s Gastrin I (human) as a cornerstone for reproducible, high-fidelity gastrointestinal studies.

• Nocodazole: Optimizing Microtubule Polymerization Inhibitor

  2026-05-29

  Nocodazole sets the benchmark for precision in microtubule dynamics and cell cycle regulation, enabling advanced experimental control for cancer research and translational studies. Learn how to maximize its potential with enhanced protocols, troubleshooting strategies, and insights from the latest kinase-regulated translation findings.

• STING agonist-1 in Cancer Immunology: Protocols & Innovation

  2026-05-29

  STING agonist-1 empowers precise STING pathway activation, enabling advanced exploration of B cell–driven immunity in cancer and inflammation research. This guide translates the latest mechanistic insights and experimental innovations into actionable workflows, troubleshooting strategies, and comparative advantages for immunology labs.

• Prestained Protein Marker (Triple Color): Precision in Neuro

  2026-05-28

  Discover how the Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) empowers translational neurobiology and pain signaling research. This article explores unique workflow advantages, protocol parameters, and critical insights from recent mechanistic studies.

• Chenodeoxycholic Acid (CDCA): Reliable FXR Tool for Metaboli

  2026-05-28

  This article explores how Chenodeoxycholic Acid (SKU B1908) addresses key challenges in nuclear receptor signaling and metabolic pathway research. Drawing on scenario-driven Q&A and literature-backed protocols, it demonstrates how CDCA delivers reproducibility and mechanistic clarity in cell-based assays. Practical guidance is anchored in validated workflows and vendor comparisons for the discerning biomedical scientist.

• LY-411575: Gamma-Secretase Inhibitor for Translational Resea

  2026-05-27

  LY-411575, a potent gamma-secretase inhibitor, enables high-precision modulation of amyloid beta production and Notch signaling in both Alzheimer's and advanced cancer workflows. APExBIO supplies this rigorously validated compound trusted by researchers for reproducible, mechanistic studies and breakthrough immunotherapy combinations.

• Betacoronaviruses and the Integrated Stress Response in Lung

  2026-05-27

  This study systematically compares how three human betacoronaviruses—SARS-CoV-2, MERS-CoV, and HCoV-OC43—differentially manipulate the integrated stress response (ISR) in lung-derived cell lines to optimize viral replication. The findings highlight distinct dependencies on eIF2α phosphorylation dynamics, suggesting new directions for host-targeted antiviral strategies.

• Pregnenolone Carbonitrile: Advancing Translational Liver Res

  2026-05-26

  This thought-leadership article analyzes Pregnenolone Carbonitrile's unique mechanistic leverage as a rodent PXR agonist and antifibrotic tool, integrating new evidence from MASLD/MASH models, and offers strategic guidance for translational researchers. The piece contextualizes PCN against the competitive landscape, details protocol considerations, and forecasts emerging research frontiers, all while referencing recent peer-reviewed findings and APExBIO's product leadership.

453 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page